PNC Financial Services Group Inc. Has $409,000 Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

PNC Financial Services Group Inc. lifted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 37.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,605 shares of the company’s stock after acquiring an additional 1,254 shares during the period. PNC Financial Services Group Inc.’s holdings in U.S. Physical Therapy were worth $409,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. BNP Paribas Financial Markets increased its holdings in U.S. Physical Therapy by 283.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after buying an additional 956 shares during the period. State Street Corp increased its stake in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the period. Stifel Financial Corp raised its holdings in U.S. Physical Therapy by 12.1% in the 3rd quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after buying an additional 6,154 shares during the last quarter. Finally, Quest Partners LLC boosted its position in U.S. Physical Therapy by 2,368.2% during the 3rd quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock worth $729,000 after buying an additional 8,265 shares during the period.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Trading Down 1.9 %

Shares of USPH opened at $74.61 on Friday. U.S. Physical Therapy, Inc. has a fifty-two week low of $74.46 and a fifty-two week high of $113.63. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of 79.37, a PEG ratio of 3.54 and a beta of 1.51. The firm has a 50 day moving average price of $85.14 and a 200-day moving average price of $87.08. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.41%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 97.83%.

Analysts Set New Price Targets

Several research analysts recently issued reports on USPH shares. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.